Previous close | 87.42 |
Open | 87.63 |
Bid | 86.86 x 900 |
Ask | 89.90 x 1100 |
Day's range | 86.53 - 88.09 |
52-week range | 60.57 - 96.12 |
Volume | |
Avg. volume | 3,421,088 |
Market cap | 52.257B |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | 37.38 |
EPS (TTM) | 2.32 |
Earnings date | 24 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 95.52 |
Salesforce, BP, The Southern, PayPal and Edwards Lifesciences are included in this Analyst Blog.
NYON, Switzerland, May 08, 2024--Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.*
Toda's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), BP p.l.c. (BP) and The Southern Company (SO).